β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapy
Background The autonomic nervous system (ANS) plays a key role in regulating tumor development and therapy resistance in various solid tumors. Within the ANS, the sympathetic nervous system (SNS) is typically associated with protumor effects. However, whether the SNS influences the antitumor efficac...
Saved in:
| Main Authors: | Miao Yu, Hui Fang, Gang Zhou, Qin Wang, David H Munn, Balveen Kaur, Rafal Pacholczyk, Bangxing Hong, Eugene Douglass, Konstantina Kyritsi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/4/e011322.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic virotherapy and the current approaches in veterinary medicine
by: Bengu Bilgic, et al.
Published: (2022-01-01) -
A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024-12-01) -
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01) -
Oncolytic virotherapy in head and neck cancer: A hope?
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01) -
The replicability of oncolytic virus: Defining conditions in tumor virotherapy
by: Jianjun Paul Tian
Published: (2011-05-01)